Effect of cyproheptadine on weight gain in malnourished children: A randomized, controlled trial

Asian Biomedicine

Volumn 4, Issue 6, 2010, Pages 977-982

  Rerksuppaphol, Sanguansak ^a   Rerksuppaphol, Lakkana ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Child; Cyproheptadine; Malnutrition; Randomized controlled trial; Weight gain

Indexed keywords

EID: 84860191852     PISSN: 19057415     EISSN: 1875855X     Source Type: Journal    
DOI: 10.2478/abm-2010-0130     Document Type: Article

References (28)

1. Food and Drug Administration of Thailand. National list of essential medicine. [cited Dec 12 2009]. Available from: http://www.thaifda.com/ed2547/.
2. Homnick DN, Marks JH, Hare KL, Bonnema SK. Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis. Pediatr Pulmonol. 2005; 40:251-6. (Pubitemid 41254498)
3. Bruera E. Current pharmacological management of anorexia in cancer patients. Oncology (Williston Park). 1992; 6:125-30; discussion: 32, 37.
4. Jatoi A, Loprinzi CL. An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care. 2001; 4:179-82. (Pubitemid 33682074)
5. Mattox TW. Treatment of unintentional weight loss in patients with cancer. Nutr Clin Pract. 2005; 20:400-10. (Pubitemid 47050810)
6. Mao X, Liang SB, Hurren R, Gronda M, Chow S, Xu GW, et al. Cyproheptadine displays preclinical activity in myeloma and leukemia. Blood. 2008; 112:760-9.
7. Powers PS, Santana C. Available pharmacological treatments for anorexia nervosa. Expert Opin Pharmacother. 2004; 5:2287-92. (Pubitemid 39489981)
8. Balog DL, Epstein ME, Amodio-Groton MI. HIV wasting syndrome: treatment update. Ann Pharmacother. 1998; 32:446-58. (Pubitemid 28166612)
9. Aguilera A, Selgas R, Diez JJ, Bajo MA, Codoceo R, Alvarez V. Anorexia in end-stage renal disease: pathophysiology and treatment. Expert Opin Pharmacother. 2001; 2:1825-38. (Pubitemid 33069477)
10. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. Technical Report Series No. 854. Geneva:WHO, 1995.
11. Mahachoklertwattana P, Wanasuwankul S, Poomthavorn P, Choubtum L, Sriphrapradang A. Short-term cyproheptadine therapy in underweight children: effects on growth and serum insulin-like growth factor-I. J Pediatr Endocrinol Metab. 2009; 22:425-32.
12. Kaplowitz PB, Jennings S. Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy. J Pediatr. 1987; 110:140-3. (Pubitemid 17211903)
13. Couluris M, Mayer JL, Freyer DR, Sandler E, Xu P, Krischer JP. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia. J Pediatr Hematol Oncol. 2008; 30:791-7.
14. Heyward VH. Practical body composition assessment for children, adults, and older adults. Int J Sport Nutr. 1998; 8:285-307.
15. Sung RY, So HK, Choi KC, Li AM, Yin J, Nelson EA. Body fat measured by bioelectrical impedance in Hong Kong Chinese children. Hong Kong Med J. 2009; 15:110-7.
16. Gharib NM, Shah P. Anthropometry and body composition of school children in Bahrain. Ann Saudi Med. 2009; 29:258-69.
17. Chakrabarty AS, Pillai RV, Anand BK, Singh B. Effect of cyproheptadine on the electrical activity of the hypothalamic feeding centres. Brain Res. 1967; 6:561-9.
18. Montgomery AM, Fletcher PJ, Burton MJ. Behavioural and pharmacological investigations of 5-HT hypophagia and hyperdipsia. Pharmacol Biochem Behav. 1986; 25:23-8. (Pubitemid 16040896)
19. Sakata T, Ookuma K, Fukagawa K, Fujimoto K, Yoshimatsu H, Shiraishi T, et al. Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res. 1988; 441:403-7. (Pubitemid 18059993)
20. Baxter MG, Miller AA, Soroko FE. The effect of cyproheptadine on food consumption in the fasted rat. Br J Pharmacol. 1970; 39:229P-30P.
21. Ghosh MN, Parvathy S. The effect of cyproheptadine on water and food intake and on body weight in the fasted adult and weanling rats. Br J Pharmacol. 1973; 48:328P-9P.
22. Rahman KM. Appetite stimulation and weight gain with cyproheptadine (periactin) in tuberculosis patients (double-blind clinical study). Med J Malaysia. 1975; 29:270-4.
23. Silverstone T, Schuyler D. The effect of cyproheptadine on hunger, calorie intake and body weight in man. Psychopharmacologia. 1975; 40:335-40.
24. Toth K, Szonyi A. The appetite stimulating and weight gain promoting effect of peritol (cyproheptadine) examined on a great number of outpatients. Ther Hung. 1976; 24:24-32.
25. Ambrosini GL, de Klerk NH, O'Sullivan TA, Beilin LJ, Oddy WH. The reliability of a food frequency questionnaire for use among adolescents. Eur J Clin Nutr. 2009; 63:1251-9.
26. Collett-Solberg PF, Misra M. The role of recombinant human insulin-like growth factor-I in treating children with short stature. J Clin Endocrinol Metab. 2008; 93:10-8.
27. Lemaire P, Brauner N, Hammer P, Trivin C, Souberbielle JC, Brauner R. Improved screening for growth hormone deficiency using logical analysis data. Med Sci Monit. 2009; 15:MT5-10.
28. Spiliotis BE, Alexandrides TK, Karystianos C, Vassilakos P, Zadik Z, Nikolakopoulou NM, et al. The insulin-like growth factor-I (IGF-I) generation test as an indicator of growth hormone status. Hormones (Athens). 2009; 8:117-28.